Evidence map›Paper›PMID 33376551›Full record

ArticleOncology letters2021

The importance of surgical margins in malignant Triton tumour of the trunk and extremities.

Panagiotis Tsagozis, Czar Louie Gaston, Felix Haglund, Jan Balko, Vaiyapuri Sumathi, Robert Grimer, Michael Parry

Abstract read
In one paragraph

Article in Oncology letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Panagiotis TsagozisThe Royal Orthopaedic Hospital Oncology Service, Royal Orthopaedic Hospital, Birmingham B31 2AP, UK.
Czar Louie GastonThe Royal Orthopaedic Hospital Oncology Service, Royal Orthopaedic Hospital, Birmingham B31 2AP, UK.
Felix HaglundDepartment of Oncology-Pathology, Karolinska Institutet, 17177 Stockholm, Sweden.
Jan BalkoDepartment of Musculoskeletal Pathology, Royal Orthopaedic Hospital NHS Foundation Trust, Birmingham B31 2AP, UK.
Vaiyapuri SumathiDepartment of Musculoskeletal Pathology, Royal Orthopaedic Hospital NHS Foundation Trust, Birmingham B31 2AP, UK.
Robert GrimerThe Royal Orthopaedic Hospital Oncology Service, Royal Orthopaedic Hospital, Birmingham B31 2AP, UK.
Michael ParryThe Royal Orthopaedic Hospital Oncology Service, Royal Orthopaedic Hospital, Birmingham B31 2AP, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant Triton tumour (MTT) is a rare variant of malignant peripheral nerve sheath tumour with partial rhabdomyosarcomatous differentiation. To the best of our knowledge, the importance of the surgical resection margins on the outcome of patients with MTT is unknown. The present study is a retrospective review of 24 patients treated for MTT of the trunk and the extremities between 1997 and 2015 in two institutions. The association of surgical margins with overall and tumour recurrence-free survival was analysed. Furthermore, the typical morphological and immunohistochemical characteristics of the tumour were described. In patients treated with curative intent (17/24), a surgical margin exceeding 1 mm was significantly associated with better overall survival and local recurrence-free survival. The oncological outcome was however poor, with only 28% of patients surviving at 5 years. Histopathologically, necrosis was a common feature, and most tumours displayed focal positivity for S100 protein and focal or strong positivity for desmin. The present results highlight the aggressive behaviour of MTTs and underline the importance of adequate surgical treatment.

Indexed as

marginrecurrencesarcomasurgerysurvivalTriton

Identifiers

PMID33376551
PMCPMC7751471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.